- About Lung Cancer
- Support & Resources
- Make a Difference
Even approved treatments do not work for everyone. Clinical trials may offer more options and present an opportunity to receive up-to-date treatment and contribute to medical science at the same time. By participating in a clinical trial, you may be part of the next big lung cancer treatment breakthrough.
Before starting treatment, ask your doctor about clinical trials. We recommend that joining a trail be considered every time a treatment decision is made.
Clinical trials are research studies that allow patients to try new treatments or combinations of treatments. All currently approved medical treatments, from aspirins to targeted therapies, went through the clinical trial process. Clinical trials are necessary for new lung cancer treatments to be found and for advancements in the treatment of the disease to occur.
Clinical trials follow a protocol, which means that all of the steps of the study are clear and are followed in the same way. There are requirements that each participant must meet, called eligibility criteria. Having criteria makes sure that nothing interferes with getting reliable information from the study.
New chemotherapy drugs, surgical and radiation techniques, vaccines, and biological therapies are a few of the treatments currently being studied in clinical trials as possible treatments for all types of lung cancer. Studies often involve adding a new treatment in combination with drugs that have already been approved.
Before you join a clinical trial, talk with your healthcare providers about the specifics of the trial.